Cargando…

An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor

The reversible process where a homogenous fluid de-mixes into two distinctively separate liquid phases is referred to as LLPS (Liquid-liquid phase separation). The resulting liquid is made up of one dilute phase and one condensed phase. An increasing number of studies have shown that the liquid-liqu...

Descripción completa

Detalles Bibliográficos
Autores principales: Durojaye, Olanrewaju Ayodeji, Sedzro, Divine Mensah, Mushiana, Talifhani, Uzoeto, Henrietta Onyinye, Cosmas, Samuel, Ajima, Judith Nnedimkpa, Ibiang, Glory Omini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685779/
http://dx.doi.org/10.1186/s43042-020-00105-0
_version_ 1783613235182698496
author Durojaye, Olanrewaju Ayodeji
Sedzro, Divine Mensah
Mushiana, Talifhani
Uzoeto, Henrietta Onyinye
Cosmas, Samuel
Ajima, Judith Nnedimkpa
Ibiang, Glory Omini
author_facet Durojaye, Olanrewaju Ayodeji
Sedzro, Divine Mensah
Mushiana, Talifhani
Uzoeto, Henrietta Onyinye
Cosmas, Samuel
Ajima, Judith Nnedimkpa
Ibiang, Glory Omini
author_sort Durojaye, Olanrewaju Ayodeji
collection PubMed
description The reversible process where a homogenous fluid de-mixes into two distinctively separate liquid phases is referred to as LLPS (Liquid-liquid phase separation). The resulting liquid is made up of one dilute phase and one condensed phase. An increasing number of studies have shown that the liquid-liquid phase separation is an important principle that underlies intracellular organization in biological systems, forming liquid condensates without a membrane envelope, otherwise known as MLOs (membraneless organelles). Such organelles include the P bodies, nucleolus and stress granules. Moreover, the regulation of many other biological processes such as signal transduction, chromatin rearrangement and RNA metabolism have been linked to the liquid-liquid phase separation.
format Online
Article
Text
id pubmed-7685779
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-76857792020-11-25 An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor Durojaye, Olanrewaju Ayodeji Sedzro, Divine Mensah Mushiana, Talifhani Uzoeto, Henrietta Onyinye Cosmas, Samuel Ajima, Judith Nnedimkpa Ibiang, Glory Omini Egypt J Med Hum Genet Correspondence The reversible process where a homogenous fluid de-mixes into two distinctively separate liquid phases is referred to as LLPS (Liquid-liquid phase separation). The resulting liquid is made up of one dilute phase and one condensed phase. An increasing number of studies have shown that the liquid-liquid phase separation is an important principle that underlies intracellular organization in biological systems, forming liquid condensates without a membrane envelope, otherwise known as MLOs (membraneless organelles). Such organelles include the P bodies, nucleolus and stress granules. Moreover, the regulation of many other biological processes such as signal transduction, chromatin rearrangement and RNA metabolism have been linked to the liquid-liquid phase separation. Springer Berlin Heidelberg 2020-11-25 2020 /pmc/articles/PMC7685779/ http://dx.doi.org/10.1186/s43042-020-00105-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Durojaye, Olanrewaju Ayodeji
Sedzro, Divine Mensah
Mushiana, Talifhani
Uzoeto, Henrietta Onyinye
Cosmas, Samuel
Ajima, Judith Nnedimkpa
Ibiang, Glory Omini
An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
title An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
title_full An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
title_fullStr An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
title_full_unstemmed An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
title_short An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
title_sort in silico llps perturbation approach in the design of a novel sars-cov-2 spike receptor-binding domain inhibitor
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685779/
http://dx.doi.org/10.1186/s43042-020-00105-0
work_keys_str_mv AT durojayeolanrewajuayodeji aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT sedzrodivinemensah aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT mushianatalifhani aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT uzoetohenriettaonyinye aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT cosmassamuel aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT ajimajudithnnedimkpa aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT ibianggloryomini aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT durojayeolanrewajuayodeji insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT sedzrodivinemensah insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT mushianatalifhani insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT uzoetohenriettaonyinye insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT cosmassamuel insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT ajimajudithnnedimkpa insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor
AT ibianggloryomini insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor